Sanofi Stops Work On Its mRNA COVID-19 Vaccine: What You Need To Know
Sanofi SA (NASDAQ:SNY) is dropping plans for its mRNA-based COVID-19 vaccine because it believes it will be too late…
Why Moderna Shares Are Falling
Shares of COVID-19 vaccine makers, including Moderna Inc (NASDAQ: MRNA), are trading lower amid continued volatility in the space as investors weigh booster shot progress.
5 Stocks Insiders Are Selling
When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go short on the stock. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.
Pfizer CEO Says People Needing COVID-19 Vaccines Every Year Is The ‘Most Likely Scenario’
Pfizer Inc (NYSE: PFE) CEO Albert Bourla said that there is a likelihood that annual booster shots of the coronavirus vaccine will be needed.
Barron’s Latest Picks And Pans: Healthcare Roundtable Picks, Dividend Aristocrats And More
This weekend's Barron's cover story offers 10 stock picks from the 2021 Barron's healthcare roundtable.
Other featured articles discuss how COVID-19 has affected travel stocks lately and whether the Dividend Aristocrat payouts are safe.
‘Fast Money Halftime Report’ Picks For September 24
On CNBC's "Fast Money Halftime Report," Jason Snipe said he likes Palo Alto Networks Inc (NYSE: PANW) and the cybersecurity theme.
This Is What Smart Money Is Betting On Moderna
Today, Benzinga's options scanner spotted 18 uncommon options trades for Moderna (NASDAQ:MRNA). The overall sentiment shows 55.56% of the big-money traders are bullish on the stock and 44.44%, bearish.